Pdt Partners, LLC Intellia Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 222,971 shares of NTLA stock, worth $5.35 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

222,971

Previous 160,997 38.49%

Holding current value

$5.35 Million

Previous $4.91 Million 24.96%

% of portfolio

0.61%

Previous 0.56%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $1.48 Million - $2.03 Million	61,974 Added 38.49%	222,971 $6.13 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $2.87 Million - $4.01 Million	123,920 Added 334.22%	160,997 $4.91 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $1.17 Million - $1.7 Million	37,077 New	37,077 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $2.45 Million - $3.36 Million	-24,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $3.56 Million - $4.76 Million	-26,900 Reduced 52.54%	24,300 $3.26 Million

Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $166,628 - $443,147	-2,737 Reduced 5.07%	51,200 $8.29 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $1.7 Million - $3.05 Million	-36,463 Reduced 40.34%	53,937 $4.33 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $129,757 - $437,785	6,891 Added 8.25%	90,400 $4.92 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $325,535 - $464,545	-18,634 Reduced 18.24%	83,509 $1.66 Million
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $10,660 - $21,886	-957 Reduced 0.93%	102,143 $2.15 Million
Q1 2020 May 15, 2020	BUY	$9.44 - $15.58 $165,983 - $273,943	17,583 Added 20.56%	103,100 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $284,916 - $482,691	27,317 Added 46.94%	85,517 $1.26 Million
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $1,150 - $1,628	-88 Reduced 0.15%	58,200 $777,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $809,037 - $1.07 Million	58,288 New	58,288 $954,000
Q1 2019 May 15, 2019	SELL	$12.79 - $17.62 $1.12 Million - $1.55 Million	-87,743 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $193 - $461	17 Added 0.02%	87,743 $1.2 Million
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $484,225 - $612,325	-18,783 Reduced 17.64%	87,726 $2.51 Million
Q2 2018 Aug 14, 2018	SELL	$20.02 - $30.79 $175,074 - $269,258	-8,745 Reduced 7.59%	106,509 $2.91 Million
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $2.24 Million - $4.03 Million	115,254 New	115,254 $2.43 Million

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

89.3M

Call Options Held

686K

Put Options Held

599K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.82B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account